| Literature DB >> 36016976 |
Ilana S Hairston1,2, Lilach Portal1,3, Tal Carmon1.
Abstract
It is postulated that negative ruminations perpetuate insomnia symptoms by increasing arousal. Less is known about the role of positive rumination. In this study, we set out to test the association between positive and negative ruminations and insomnia symptoms in a non-clinical sample, asking whether reappraisal and suppression moderate the relationship between rumination types and symptoms of insomnia.Entities:
Keywords: affect regulation; cognitive arousal; insomnia; reappraisal; suppression (psychology)
Year: 2022 PMID: 36016976 PMCID: PMC9396259 DOI: 10.3389/fpsyt.2022.889810
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Figure 1Proposed moderation model. Negative Rumination and Dampening are predicted to increase subjective sleep difficulty whereas two predictions (either increase or decrease) for Positive Rumination are possible. Reappraisal is predicted to attenuate the effects of rumination whereas Suppression is expected to enhance the effects. Additionally, Reappraisal is independently expected to reduce subjective sleep difficulty, and Suppression to increase.
Sociodemographic characteristics.
|
|
|
|
|---|---|---|
| Gender | ||
| Women | 206 | 58.7 |
| Men | 145 | 41.3 |
| Marital status | ||
| Single | 108 | 30.6 |
| Married/relationship | 227 | 65.0 |
| Divorced/separated/widowed | 16 | 4.6 |
| Education | ||
| ≤ 12 years | 155 | 44.2 |
| 12–15 | 117 | 33.3 |
| >15 | 79 | 22.5 |
| Religion | ||
| Jewish | 346 | 98.3 |
| Muslim | 2 | 0.6 |
| Christian | 2 | 0.6 |
| Druze | 1 | 0.3 |
| Taking meds | ||
| Yes | 22 | 6.3 |
| Metabolic health diagnoses | ||
| None | 340 | 96.9 |
| 1 or more | 11 | 3.1 |
| Mental health diagnoses | ||
| None | 291 | 82.9 |
| 1–2 | 56 | 14.0 |
| 3 or more | 4 | 1.1 |
| ISI | ||
| No insomnia (<8) | 103 | 29.3 |
| Subclinical symptoms (8–13) | 142 | 40.3 |
| Moderate (14–21) | 86 | 24.4 |
| Severe (= >22) | 21 | 6.0 |
Descriptive statistics and first-order correlations.
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [1] | Age | 30.42 [6.01] | 1 | ||||||||||
| [2] | Gender | 0 = F |1=M | 0.078 | 1 | |||||||||
| [3] | ISI | 11.39 [6.6] | 0.113* | −0.145** | 1 | ||||||||
| [4] | Bedtime | 23:37 [1:15] | −0.091 | −0.037 | 0.043 | 1 | |||||||
| [5] | Wake time | 7:17 [1:22] | −0.194** | 0.060 | −0.262** | 0.558** | 1 | ||||||
| [6] | TST | 6.4 [1.33] | −0.121* | 0.146** | −0.708** | −0.115* | 0.472** | 1 | |||||
| [7] | SOL | 35.51 [26.03] | −0.006 | −0.121* | 0.263** | 0.121* | −0.012 | −0.259** | 1 | ||||
| [8] | Reapp. | 4.51 [1.15] | −0.045 | 0.041 | −0.228** | 0.052 | −0.010 | 0.122* | −0.030 | 1 | |||
| [9] | Supp. | 3.74 [1.75] | 0.043 | −0.179** | 0.363** | −0.070 | −0.151** | −0.359** | 0.084 | −0.397** | 1 | ||
| [10] | NR | 1.89 [0.71] | −0.092 | −0.260** | 0.567** | 0.083 | −0.100 | −0.488** | 0.151** | −0.392** | 0.572** | 1 | |
| [11] | PR | 1.99 [0.88] | −0.007 | 0.209** | −0.128* | −0.004 | −0.014 | 0.133* | 0.026 | 0.373** | −0.637** | −0.485** | 1 |
| [12] | Damp. | 1.74 [0.7] | −0.026 | −0.222** | 0.519** | 0.042 | −0.074 | −0.331** | 0.021 | −0.368** | 0.425** | 0.738** | −0.325** |
ISI, insomnia severity index; TST, totals sleep time; SOL, sleep onset latency; Reapp., Reappraisal factor from EFA of the ERQ; Suppr., Suppression factor from EFA of the ERQ; NR, negative rumination factor from EFA of the Ruminative Response Scale; PR, positive rumination derived from EFA of the Response to Positive Affect; Damp., Dampening derived from the EFA of Response to Positive Affect; *p <0.05; **p <0.01.
Moderation model estimates for the association between negative rumination and insomnia symptoms.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| NR | 3.685 [0.29] | 0.56*** | 3.11, 4.26 | 1.00 | 3.46 [0.37] | 0.52*** | 2.74, 4.19 | 1.56 | 3.35 [0.37] | 0.51*** | 2.62, 4.09 | 1.62 |
| Reap | 0.04 [0.33] | 0.01 | −0.61, 0.69 | 1.24 | 0.10 [0.33] | 0.02 | −0.55, 0.76 | 1.28 | ||||
| Supp | 0.41 [0.37] | 0.06 | −0.32, 1.13 | 1.60 | 0.49 [0.37] | 0.07 | −0.24, 1.21 | 1.64 | ||||
| NR * Reap | 0.20 [0.36] | 0.03 | −0.51, 0.91 | 1.23 | ||||||||
| NR * Supp | 0.63 [0.37] | 0.08 | −0.10, 1.37 | 1.25 | ||||||||
| Adjusted | 0.309 | 0.308 | 0.309 | |||||||||
| 157.62*** | 52.84*** | 32.36*** | ||||||||||
| 0.002 | 0.006 | |||||||||||
| 0.63 | 1.44 | |||||||||||
| Cohen | N/A | N/A | ||||||||||
NR, negative rumination from RRS; Reap, Reappraisal from ERQ; Supp, Suppression from ERQ; Cohen F.
Figure 2Testing the moderating effects of Reappraisal (A,C,E) and Suppression (B,D,F) on the association between Negative Rumination (A,B), Postive Rumination (C,D) and Dampening (E,F) with insomnia Symptoms as reported on the ISI. The ordinate in each graph is the standardized predicted ISI derived from the moderation model for each rumination type. The lines depict the slope and intercept of the association between factors at three levels of the moderator: −1 standard deviation (SD, full black line), mean (hashed black line), +1 SD (hashed gray line).
Moderation model for the association between positive rumination and insomnia symptoms.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| PR | −0.92 [0.40] | −0.12* | −1.70, −0.14 | 1.00 | 1.52 [0.48] | 0.20*** | 0.57, 2.47 | 1.71 | 0.86 [0.51] | 0.12 | −0.13, 1.63 | 2.01 |
| Reap | −0.74 [0.36] | −0.11* | −1.45, −0.03 | 1.23 | −0.87 [0.36] | −0.13 | −1.59, −0.16 | 1.29 | ||||
| Supp | 2.92 [0.43] | 0.45*** | 2.08, 3.77 | 1.79 | 2.48 [0.44] | 0.38*** | 1.62, 3.34 | 1.92 | ||||
| PR * Reap | 0.86 [0.37] | 0.13* | 0.14, 1.59 | 1.25 | ||||||||
| PR * Supp | −0.96 [0.42] | −0.13* | −1.78, −0.13 | 1.35 | ||||||||
| Adjusted | 0.012 | 0.154 | 0.189 | |||||||||
| 5.36* | 22.27*** | 17.30*** | ||||||||||
| 0.146 | 0.039 | |||||||||||
| 30.28*** | 8.41 | |||||||||||
| Cohen | 0.17 | 0.05 | ||||||||||
PR, positive rumination from PRA; Reap, Reappraisal from ERQ; Supp, Suppression from ERQ; Cohen F.
Moderation model for the association between dampening and insomnia symptoms.
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Damp | 2.24 [0.33] | 0.34*** | 1.57, 2.88 | 1.00 | 1.54 [0.35] | 0.23*** | 0.85, 2.23 | 1.21 | 1.55 [0.35] | 0.24*** | 0.86, 2.23 | 1.21 |
| Reap | −1.91 [0.36] | −0.03 | −0.90, 0.52 | 1.27 | −0.13 [0.36] | −0.02 | −0.85, 0.58 | 1.29 | ||||
| Supp | 1.76 [0.36] | 0.27*** | 1.05, 2.46 | 1.28 | 1.83 [0.36] | 0.28*** | 1.13, 2.53 | 1.29 | ||||
| Damp * Reap | −0.61 [0.33] | −0.09 | 1.25, 0.03 | 1.07 | ||||||||
| Damp * Supp | 0.59 [0.36] | 0.08 | −0.11, 1.29 | 1.06 | ||||||||
| Adjusted | 0.111 | 0.176 | 0.190 | |||||||||
| 44.85*** | 25.84*** | 17.38*** | ||||||||||
| 0.069 | 0.019 | |||||||||||
| 14.59*** | 4.01* | |||||||||||
| Cohen | 0.08 | 0.02 | ||||||||||
Damp, Dampening from PRA; Reap, Reappraisal from ERQ; Supp, Suppression from ERQ; Cohen F.